Veltri RW - Search Results

1

Evaluation of two mitochondrial DNA biomarkers for prostate cancer detection.

Maragh S, Veltri RW, Lund SP, Mangold L, Isharwal S, Christudass CS, Partin AW, Humphreys EB, Sorbara L, Srivastava S, Wagner PD. Maragh S, et al. Among authors: veltri rw. Cancer Biomark. 2015;15(6):763-73. doi: 10.3233/CBM-150518. Cancer Biomark. 2015. PMID: 26406418

2

Prognostic value of Her-2/neu and DNA index for progression, metastasis and prostate cancer-specific death in men with long-term follow-up after radical prostatectomy.

Isharwal S, Miller MC, Epstein JI, Mangold LA, Humphreys E, Partin AW, Veltri RW. Isharwal S, et al. Among authors: veltri rw. Int J Cancer. 2008 Dec 1;123(11):2636-43. doi: 10.1002/ijc.23838. Int J Cancer. 2008. PMID: 18767043 Free PMC article.

3

DNA Ploidy as surrogate for biopsy gleason score for preoperative organ versus nonorgan-confined prostate cancer prediction.

Isharwal S, Miller MC, Epstein JI, Mangold LA, Humphreys E, Partin AW, Veltri RW. Isharwal S, et al. Among authors: veltri rw. Urology. 2009 May;73(5):1092-7. doi: 10.1016/j.urology.2008.09.060. Epub 2009 Feb 3. Urology. 2009. PMID: 19193410 Free PMC article.

4

Nuclear morphometry, epigenetic changes, and clinical relevance in prostate cancer.

Veltri RW, Christudass CS. Veltri RW, et al. Adv Exp Med Biol. 2014;773:77-99. doi: 10.1007/978-1-4899-8032-8_4. Adv Exp Med Biol. 2014. PMID: 24563344 Free PMC article.

5

Association of [-2]proPSA with biopsy reclassification during active surveillance for prostate cancer.

Tosoian JJ, Loeb S, Feng Z, Isharwal S, Landis P, Elliot DJ, Veltri R, Epstein JI, Partin AW, Carter HB, Trock B, Sokoll LJ. Tosoian JJ, et al. J Urol. 2012 Oct;188(4):1131-6. doi: 10.1016/j.juro.2012.06.009. Epub 2012 Aug 15. J Urol. 2012. PMID: 22901577 Free PMC article.

6

Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge.

Veltri RW, Miller MC, Mangold LA, O'Dowd GJ, Epstein JI, Partin AW. Veltri RW, et al. J Urol. 2002 Jul;168(1):100-4. J Urol. 2002. PMID: 12050500

7

Impact of age on total and complexed prostate-specific antigen cutoffs in a contemporary referral series of men with prostate cancer.

Veltri RW, Miller MC, O'dowd GJ, Partin AW. Veltri RW, et al. Urology. 2002 Oct;60(4 Suppl 1):47-52. doi: 10.1016/s0090-4295(02)01695-3. Urology. 2002. PMID: 12384163

8

Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/ml.

Khan MA, Partin AW, Rittenhouse HG, Mikolajczyk SD, Sokoll LJ, Chan DW, Veltri RW. Khan MA, et al. Among authors: veltri rw. J Urol. 2003 Sep;170(3):723-6. doi: 10.1097/01.ju.0000086940.10392.93. J Urol. 2003. PMID: 12913682

9

Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?

Khan MA, Carter HB, Epstein JI, Miller MC, Landis P, Walsh PW, Partin AW, Veltri RW. Khan MA, et al. Among authors: veltri rw. J Urol. 2003 Dec;170(6 Pt 1):2274-8. doi: 10.1097/01.ju.0000097124.21878.6b. J Urol. 2003. PMID: 14634395

10

Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy.

Khan MA, Walsh PC, Miller MC, Bales WD, Epstein JI, Mangold LA, Partin AW, Veltri RW. Khan MA, et al. Among authors: veltri rw. Cancer. 2003 Dec 15;98(12):2583-91. doi: 10.1002/cncr.11852. Cancer. 2003. PMID: 14669277 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

154 results

Search Page

Filters